Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$29.1K
444.00 shares
What this filing means
ROBIN HOWARD W plans to sell 444.00 shares of NEKTAR THERAPEUTICS valued at approximately $29.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/19/2026ACC: 0001959173-26-003768
DirectorOfficer· President & CEO
Since Aug 2018
444.00
Shares to sell
$29.1K
Approx. market value
444.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/15/2026
444.00Total acquired444.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Vesting Compensation | 444.00 | — |
| Total | 444.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
444.00
Market value
$29.1K
5/19/2026
Total
Units
444.00
Value
$29.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/19/2026 | 444.00 | $29.1K | NASDAQ | Planned |
| Total | 444.00 | $29.1K | ||